Form 8-K - Current report:
SEC Accession No. 0001193125-25-331009
Filing Date
2025-12-23
Accepted
2025-12-23 16:30:25
Documents
10
Period of Report
2025-12-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20251219.htm   iXBRL 8-K 73837
  Complete submission text file 0001193125-25-331009.txt   180089

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20251219.xsd EX-101.SCH 24852
12 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20251219_htm.xml XML 4672
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 251601043
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)